Symbol | Definition | Sample value used | Parameter range |
---|---|---|---|
C U | Unvaccinated female children | (state variable) | |
A U | Unvaccinated adult women | (state variable) | |
C V | Vaccinated female children | (state variable) | |
A V | Vaccinated adult women | (state variable) | |
I U | Uninfected adult women | (state variable) | |
I V | Infected adult women | (state variable) | |
M | Uninfected men | (state variable) | |
N | Infected men | (state variable) | |
π W | Rate of appearance of new females | 50 per year | 0–100 |
π M | Rate of appearance of new males | 50 per year | 0–100 |
ε | Vaccine immunogenicity in female children | 98% | 75–98% |
| Vaccine immunogenicity in adult women | 98% | 75–98% |
p | Proportion of female children vaccinated | 77% | 0–100% |
| Proportion of adult women vaccinated | 40% | 0–100% |
μ C | Mortality rate of children | 1/70 years -1 | 1/140–1/13 |
μ | Leaving rate of adults | 1/10 years-1 | 1/12–1 |
α | Rate of progression of female children to sexually activity |
| 1/12–1 |
c | Attentuation constant | 0.15 years-1 | 0–0.3 |
γ | Maximal possible rate of adult vaccination | 0.1 | 0–0.2 |
| Rate at which unvaccinated adult women are vaccinated |
| |
β N | Probability of infection of a woman by an infected man | 0.00056 | 0–0.00112 |
β M | Probability of infection of a man by an infected woman | 0.0003 | 0–0.0006 |
ψ | Vaccine efficacy | 95% | 85–95% |